Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

The ApoC-I content of VLDL particles is associated with plaque size in persons with carotid atherosclerosis.

Notø AT, Mathiesen EB, Brox J, Björkegren J, Hansen JB.

Lipids. 2008 Jul;43(7):673-9. doi: 10.1007/s11745-008-3193-2. Epub 2008 May 29.

PMID:
18509687
2.

Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.

Björkegren J, Silveira A, Boquist S, Tang R, Karpe F, Bond MG, de Faire U, Hamsten A.

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1470-4.

PMID:
12231568
3.

The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis.

Hansen JB, Fernández JA, Notø AT, Deguchi H, Björkegren J, Mathiesen EB.

J Lipids. 2011;2011:271062. doi: 10.1155/2011/271062. Epub 2011 Jul 6.

5.

The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.

Hamsten A, Silveira A, Boquist S, Tang R, Bond MG, de Faire U, Björkegren J.

J Am Coll Cardiol. 2005 Apr 5;45(7):1013-7.

6.
7.

High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.

Yamamoto R, Sacks FM, Hu FB, Rosner B, Furtado JD, Aroner SA, Ferrannini E, Baldi S, Kozakova M, Balkau B, Natali A, Jensen MK; RISC Investigators.

Atherosclerosis. 2018 Feb;269:92-99. doi: 10.1016/j.atherosclerosis.2017.12.029. Epub 2018 Jan 2.

PMID:
29351856
8.

Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.

Amor AJ, Catalan M, Pérez A, Herreras Z, Pinyol M, Sala-Vila A, Cofán M, Gilabert R, Ros E, Ortega E.

Atherosclerosis. 2016 Apr;247:161-9. doi: 10.1016/j.atherosclerosis.2016.02.014. Epub 2016 Feb 17.

PMID:
26921744
9.

Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.

Breyer ED, Le NA, Li X, Martinson D, Brown WV.

J Lipid Res. 1999 Oct;40(10):1875-82.

10.

Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins.

Grønholdt ML, Nordestgaard BG, Nielsen TG, Sillesen H.

Stroke. 1996 Dec;27(12):2166-72.

PMID:
8969774
11.

White adipose tissue apolipoprotein C-I secretion in relation to delayed plasma clearance of dietary fat in humans.

Wassef H, Salem H, Bissonnette S, Baass A, Dufour R, Davignon J, Faraj M.

Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2785-93. doi: 10.1161/ATVBAHA.112.300306. Epub 2012 Sep 20.

PMID:
22995522
12.

Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.

Aalto-Setälä K, Weinstock PH, Bisgaier CL, Wu L, Smith JD, Breslow JL.

J Lipid Res. 1996 Aug;37(8):1802-11.

13.

Alterations of VLDL composition during alimentary lipemia.

Björkegren J, Hamsten A, Milne RW, Karpe F.

J Lipid Res. 1997 Feb;38(2):301-14.

14.

Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.

Zheng C, Khoo C, Ikewaki K, Sacks FM.

J Lipid Res. 2007 May;48(5):1190-203. Epub 2007 Feb 21.

15.
16.

Atherogenic Lipoprotein Subfractions and Carotid Atherosclerosis in Menopausal Women.

Iannuzzi A, Gentile M, Iannuzzo G, Covetti G, Panico C, Mattiello A, Fata E, D'Elia L, Michele M, Rubba P.

Angiology. 2018 Sep;69(8):666-671. doi: 10.1177/0003319717744315. Epub 2017 Nov 27.

PMID:
29179568
17.

Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.

Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.

Metabolism. 2001 Jan;50(1):112-9.

PMID:
11172484
18.
19.

High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.

Wojczynski MK, Glasser SP, Oberman A, Kabagambe EK, Hopkins PN, Tsai MY, Straka RJ, Ordovas JM, Arnett DK.

Lipids Health Dis. 2011 Oct 18;10:181. doi: 10.1186/1476-511X-10-181.

20.

Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.

Westerterp M, de Haan W, Berbée JF, Havekes LM, Rensen PC.

J Lipid Res. 2006 Jun;47(6):1203-11. Epub 2006 Mar 14.

Supplemental Content

Support Center